Larvol Delta - BioAge-Labs-Announces-Plans-for-Phase-2-Trial-of-FirstinClass-Apelin-Receptor-Agonist-BGE105Azelaprag-CoAdministered-With-Tirzepatide-for-Treatment-of-Obesity-in-Collaboration-With-Lillys-Chorus-Organization

azelaprag (BGE-105) - BioAge Labs

Mounjaro (tirzepatide) - Eli Lilly

https://www.businesswire.com/news/home/20231026896677/en/BioAge-Labs-Announces-Plans-for-Phase-2-Trial-of-First-in-Class-Apelin-Receptor-Agonist-BGE-105Azelaprag-Co-Administered-With-Tirzepatide-for-Treatment-of-Obesity-in-Collaboration-With-Lilly%E2%80%99s-Chorus-Organization

Oct 26, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next